1.Kuang J,et al.Sacubitril/valsartan attenuates inflammation and myocardial fibrosis in Takotsubo-like cardiomyopathy.J Mol Cell Cardiol. 2025 Mar;200:24-39. doi: 10.1016/j.yjmcc.2025.01.003. Epub 2025 Jan 18.
2.Wu K*,Kuang J*,Huang N*, et al. Shouhui Tongbian Capsule ameliorates obesity by enhancing energy consumption and promoting lipolysis via cAMP-PKA pathway. Phytomedicine. 2025 Mar;138:156375. doi: 10.1016/j.phymed.2025.156375. Epub 2025 Jan 7.PMID: 39848021.
3.Yan Z, ...,Kuang J#, Lu Q#.Safety and efficacy of using Judkins left 3.5 guiding catheters for transradial right coronary artery intervention.Eur Rev Med Pharmacol Sci. 2023 Mar;27(6):2341-2349. doi: 10.26355/eurrev_202303_31769.PMID: 37013753
4.Kuang J, et al. Reduced Insulin-Like Growth Factor 1 Is Associated with Insulin Resistance in Obese Prepubertal Boys. BioMed research international. 2021;2021:6680316.
5.Kuang J,et al. Mechanism of Yangxinshi Intervention on Cardiac Fibrosis in Diabetic Cardiomyopathy Based on Network Pharmacology.Evidence-based complementary and alternative medicine : eCAM.2022;2022:3968494.
6.Kuang J,et al. The Role of Sirt6 in Obesity and Diabetes.Frontiers in physiology.2018;9:135.
7.Kuang J, et al. Fat-Specific Sirt6 Ablation Sensitizes Mice to High-Fat Diet-Induced Obesity and Insulin Resistance by Inhibiting Lipolysis.Diabetes.2017;66(5):1159-1171.
8.Kuang J*, Hou X*, et al. Identification of insulin as a novel retinoic acid receptor-related orphan receptor α target gene.FEBS letters.2014;588(6):1071-1079.
9.Xu SC*,Kuang JY*, et al. Association between fibroblast growth factor 7 and the risk of chronic obstructive pulmonary disease.Acta pharmacologica Sinica.2012;33(8):998-1003.